Atrial Switch Operation (Senning) — Procedure Concepts

The Senning operation is an atrial-level redirection procedure: it restores physiologic streaming without altering ventriculo–arterial connections. Thus, the anatomical RV remains the systemic ventricle and the anatomical LV remains the subpulmonary ventricle, while venous pathways are re-routed so that pulmonary venous blood reaches the aorta and systemic venous blood reaches the pulmonary artery.

1) Core principle: build two unobstructed, growth-tolerant baffles

Senning is best conceptualized as constructing two intracardiac “highway lanes”:

1. Systemic venous pathway: SVC/IVC → mitral valve → LV → PA
2. Pulmonary venous pathway: PV/LA → tricuspid valve → RV → Ao

Durability depends less on the name of the atrial switch and more on whether each pathway is:

• Wide: minimal gradients at rest and with growth; avoid “tunnel physiology.”
• Non-kinking: gentle curvature and adequate cross-sectional area at transition zones.
• Rhythm-conscious: atrial geometry + suture burden influence late sinus node dysfunction and atrial tachyarrhythmias.

2) Stepwise surgical concept (matching the schematic workflow)

Step 1 — Right atriotomy: exposure and “map-making”

• A RA incision provides the working window.
• Before committing to flap lines, re-confirm: IVC orifice, atrial septum, and the spatial relationship of venous entries to AV valves.
• This is where “millimeters matter”: a subtle offset can become late baffle stenosis.

Step 2 — Create the atrial septal flap toward the LA

• Senning leverages autologous atrial tissue: the atrial septal flap is directed toward the LA side.
• This flap becomes a structural wall that helps separate pulmonary venous return from the systemic venous pathway.

Step 3 — “Roof” the pulmonary venous chamber: septal flap + patch augmentation

• The pulmonary venous side must behave as a low-pressure, low-resistance reservoir.
• Patch augmentation is used when native tissue is insufficient, with one overriding goal:

avoid a narrow PV tunnel → a classic substrate for pulmonary venous baffle obstruction (often clinically subtle until late).

Step 4 — Construct the systemic venous pathway: RA flap ± patch

• The RA flap forms the systemic venous channel, directing IVC/SVC flow toward the mitral valve (LV inflow).
• Patch augmentation is not a “compromise”—it is frequently the difference between a technically complete operation and a durable, non-stenotic geometry, especially in small atria.

Step 5 — Left atriotomy: facilitate pulmonary venous pathway completion

• An LA incision supports final shaping of the pulmonary venous pathway.
• This step reinforces a key concept: the pulmonary venous chamber must be designed, not merely “closed,” because ridges/twists can function like a supravalvar inflow stenosis.

Step 6 — Patch completion and smoothing (PV → tricuspid → systemic RV)

• Final shaping often uses a patch to create a wide, laminar pulmonary venous pathway.
• Aim for a smooth transition zone: PVs → atrial chamber → tricuspid valve, avoiding shelf-like narrowing that later presents as desaturation, exercise limitation, or pulmonary venous hypertension.

3) Senning vs Mustard: a practical, outcomes-informed perspective

• Senning: primarily autologous atrial tissue flaps, potentially more growth-friendly geometry when tissue is adequate.
• Mustard: typically prosthetic/pericardial baffle-based, often simpler construction but more reliance on non-native material.

In comparative cohorts, Senning has been associated with slightly better functional status and fewer baffle-related complications in long-term follow-up, although late morbidity remains substantial across both atrial switch populations. [2,4] (PubMed)

4) Technical “no-regret” checkpoints (where late failures are born)

A. Caliber (think: future adult-sized pathways)

• Systemic venous baffle: no pinching near SVC/IVC entries; avoid narrowing toward the mitral inflow axis.
• Pulmonary venous baffle: preserve a broad PV chamber—do not trade space for “neat closure.”

B. Geometry (think: fluid mechanics)

• Avoid sharp turns: the baffle should behave like a gentle curve, not an “S-bend.”
• Prevent pathway “crowding”: competition for atrial volume predicts obstruction and reintervention.

C. Rhythm preservation (think: arrhythmia as structural disease)

• Minimize unnecessary atrial suture lines and tension vectors.
• Assume that scar corridors + atrial dilation will remodel over decades and become arrhythmogenic.

5) Late outcomes: what atrial switch “buys,” and what it “costs”

A. Survival is good, but morbidity is the rule—especially beyond adolescence

Large Senning series demonstrate excellent long-term survival, with one 20-year follow-up cohort reporting sustained survival alongside progressive late morbidity. [1] (PubMed)

A nationwide multicenter cohort extending up to 30 years likewise showed favorable survival but a growing burden of late complications in atrial switch survivors. [2] (PubMed)

B. Systemic RV dysfunction and systemic AV (tricuspid) regurgitation: the central late phenotype

• The anatomical RV is asked to sustain systemic afterload for life → remodeling and dysfunction may emerge gradually. [1,3,6] (PubMed)
• Tricuspid regurgitation often tracks systemic RV dilation and is repeatedly linked to adverse outcomes and heart failure trajectories. [1,3]

C. Arrhythmias are not incidental—they are predictable and progressive

• Long-term Senning follow-up shows a marked decline in durable sinus rhythm over time, consistent with atrial remodeling and suture-line substrate. [1] (PubMed)
• Broader atrial switch cohorts confirm that atrial tachyarrhythmias and conduction disease constitute a major component of late morbidity. [5,6] (PubMed)

D. Baffle obstruction/leak: the “geometry complication”

• Systemic venous baffle stenosis → elevated venous pressures, hepatic congestion, reduced exercise tolerance.
• Pulmonary venous baffle stenosis → pulmonary venous hypertension and dyspnea (often under-recognized early).
• Baffle leak → residual mixing/desaturation; may become clinically relevant with evolving hemodynamics.

Long-term comparisons suggest Senning may have fewer baffle complications than Mustard in some cohorts, but neither procedure is immune. [2,4,5]

6) Contemporary risk stratification: what predicts adverse events today?

Modern multicenter analyses of atrial switch survivors identify independent predictors of adverse outcomes, including:

• Ventricular arrhythmia
• Heart failure admission
• Complex anatomy
• Prolonged QRS duration
• Severe systemic RV dysfunction [3] (PubMed)

This evidence supports a practical surveillance mindset: atrial switch follow-up is not “annual echo only,” but rather longitudinal tracking of systemic RV function, TR severity, QRS trajectory, and arrhythmia burden, with a low threshold for advanced imaging and electrophysiology involvement.

7) Where Senning still matters (2025-era framing)

• Late-presenting d-TGA with an inadequately conditioned LV remains a historical—and occasionally relevant—context in which atrial switch principles explain physiology and decision-making.
• Atrial redirection concepts also remain foundational in the double-switch pathway for selected ccTGA physiology, where atrial-level streaming is paired with arterial-level correction.

References

[1] Roubertie F, Thambo JB, Bretonneau A, Iriart X, Laborde N, Baudet E, Roques X. Late outcome of 132 Senning procedures after 20 years of follow-up. Ann Thorac Surg. 2011;92(6):2206-2213.

[2] Moons P, Gewillig M, Sluysmans T, Verhaaren H, Viart P, Massin M, Suys B, Budts W, Pasquet A, De Wolf D, Vliers A. Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicentre study in Belgium. Heart. 2004;90(3):307-313.

[3] Broberg CS, van Dissel A, Minnier J, Aboulhosn J, Kauling RM, et al. Long-Term Outcomes After Atrial Switch Operation for Transposition of the Great Arteries. J Am Coll Cardiol. 2022;80(10):951-963.

[4] Helbing WA, Hansen B, Ottenkamp J, et al. Long-term results of atrial correction for transposition of the great arteries. Comparison of Mustard and Senning operations. J Thorac Cardiovasc Surg. 1994;108(2):363-372.

[5] Dos L, Teruel L, Ferreira IJ, Rodriguez-Larrea J, Miro L, Girona J, Albert DC, Gonçalves A, Murtra M, Casaldaliga J. Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries. Heart. 2005;91(5):652-656.

[6] Dobson R, Danton M, Nicola W, Hamish W. The natural and unnatural history of the systemic right ventricle in adult survivors. J Thorac Cardiovasc Surg. 2013;145(6):1493-1501; discussion 1501-1503.